Urinary p-cresol is elevated in small children with severe autism spectrum disorder

References

• Alberti A, Pirrone P, Elia M, Waring RH, Romano C. (1999). Sulphation deficit in “low-functioning” autistic children: a pilot study. Biol Psychiatry 46:420–424.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press.
   Google Scholar
• Ashwood P, Wills S, Van de Water J. (2006). The immune response in autism: a new frontier for autism research. J Leukoc Biol 80:1–15.
   PubMed Web of Science ®Google Scholar
• Birkett AM, Jones GP, Muir JG. (1995). Simple high-performance liquid chromatographic analysis of phenol and p-cresol in urine and feces. J Chromatogr B, Biomed Appl 674:187–191.
   PubMed Web of Science ®Google Scholar
• Bright DA, Healey N. (2003). Contaminant risks from biosolids land application: contemporary organic contaminant levels in digested sewage sludge from five treatment plants in Greater Vancouver, British Columbia. Environ Pollut 126:39–49.
   PubMed Web of Science ®Google Scholar
• Buie T, Campbell DB, Fuchs GJ 3rd, Furuta GT, Levy J, Vandewater J, Whitaker AH, Atkins D, Bauman ML, Beaudet AL, Carr EG, Gershon MD, Hyman SL, Jirapinyo P, Jyonouchi H, Kooros K, Kushak R, Levitt P, Levy SE, Lewis JD, Murray KF, Natowicz MR, Sabra A, Wershil BK, Weston SC, Zeltzer L, Winter H. (2010). Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report. Pediatrics 125(Suppl 1):S1–18.
   PubMed Web of Science ®Google Scholar
• Cafaro V, Notomista E, Capasso P, Di Donato A. (2005). Mutation of glutamic acid 103 of toluene o-xylene monooxygenase as a means to control the catabolic efficiency of a recombinant upper pathway for degradation of methylated aromatic compounds. Appl Environ Microbiol 71:4744–4750.
   PubMed Web of Science ®Google Scholar
• Cerini C, Dou L, Anfosso F, Sabatier F, Moal V, Glorieux G, De Smet R, Vanholder R, Dignat-George F, Sampol J, Berland Y, Brunet P. (2004). P-cresol, a uremic retention solute, alters the endothelial barrier function in vitro. Thromb Haemost 92:140–150.
   PubMed Web of Science ®Google Scholar
• Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK. (2009). Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 106:14728–14733.
   PubMed Web of Science ®Google Scholar
• D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, Cardi E, Giardini O. (1996). Abnormal intestinal permeability in children with autism. Acta Paediatr 85:1076–1079.
   PubMed Web of Science ®Google Scholar
• de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C. (2010). Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51:418–424.
   PubMed Web of Science ®Google Scholar
• De Smet R, Van Kaer J, Van Vlem B, De Cubber A, Brunet P, Lameire N, Vanholder R. (2003). Toxicity of free p-cresol: a prospective and cross-sectional analysis. Clin Chem 49:470–478.
   PubMed Web of Science ®Google Scholar
• Filipek PA, Accardo PJ, Baranek GT, Cook EH Jr, Dawson G, Gordon B, Gravel JS, Johnson CP, Kallen RJ, Levy SE, Minshew NJ, Ozonoff S, Prizant BM, Rapin I, Rogers SJ, Stone WL, Teplin S, Tuchman RF, Volkmar FR. (1999). The screening and diagnosis of autistic spectrum disorders. J Autism Dev Disord 29:439–484.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Molitoris D, Song Y, Liu C, Vaisanen ML, Bolte E, McTeague M, Sandler R, Wexler H, Marlowe EM, Collins MD, Lawson PA, Summanen P, Baysallar M, Tomzynski TJ, Read E, Johnson E, Rolfe R, Nasir P, Shah H, Haake DA, Manning P, Kaul A. (2002). Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35:S6–S16.
   PubMed Web of Science ®Google Scholar
• Finegold SM, Dowd SE, Gontcharova V, Liu C, Henley KE, Wolcott RD, Youn E, Summanen PH, Granpeesheh D, Dixon D, Liu M, Molitoris DR, Green JA 3rd. (2010). Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16:444–453.
   PubMed Web of Science ®Google Scholar
• Fombonne E. (2002). Epidemiological trends in rates of autism. Mol Psychiatry 7(Suppl 2):S4–S6.
   PubMed Web of Science ®Google Scholar
• Freitag CM. (2007). The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry 12:2–22.
   PubMed Web of Science ®Google Scholar
• Hopkins MJ, Sharp R, Macfarlane GT. (2002). Variation in human intestinal microbiota with age. Dig Liver Dis 34(Suppl 2):S12–S18.
   PubMedGoogle Scholar
• Jyonouchi H, Geng L, Ruby A, Zimmerman-Bier B. (2005). Dysregulated innate immune responses in young children with autism spectrum disorders: their relationship to gastrointestinal symptoms and dietary intervention. Neuropsychobiology 51:77–85.
   PubMed Web of Science ®Google Scholar
• Kawakami K, Kojima K, Makino I, Kato I, Onoue M. (2007). Fasting enhances p-Cresol production in the rat intestinal tract. Exp Anim 56:301–307.
   PubMed Web of Science ®Google Scholar
• King RA, May BL, Davies DA, Bird AR. (2009). Measurement of phenol and p-cresol in urine and feces using vacuum microdistillation and high-performance liquid chromatography. Anal Biochem 384:27–33.
   PubMed Web of Science ®Google Scholar
• Kitagawa A. (2001). Effects of cresols (o-, m-, and p-isomers) on the bioenergetic system in isolated rat liver mitochondria. Drug Chem Toxicol 24:39–47.
   PubMed Web of Science ®Google Scholar
• Lintas C, Sacco R, Garbett K, Mirnics K, Militerni R, Bravaccio C, Curatolo P, Manzi B, Schneider C, Melmed R, Elia M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Persico AM. (2009). Involvement of the PRKCB1 gene in autistic disorder: significant genetic association and reduced neocortical gene expression. Mol Psychiatry 14:705–718.
   PubMed Web of Science ®Google Scholar
• Lord C, Rutter M, DiLavore PC, Risi S. (2002). ADOS, Autism Diagnostic Observation Schedule. Los Angeles, CA: Western Psychological Services [Italian version by Tancredi R, Saccani M, Persico AM, Parrini B, Igliozzi R, Faggioli R, editors (2005). Florence, Italy: Organizzazioni Speciali].
   Google Scholar
• Parracho HM, Bingham MO, Gibson GR, McCartney AL. (2005). Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54:987–991.
   PubMed Web of Science ®Google Scholar
• Persico AM, Bourgeron T. (2006). Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29:349–358.
   PubMed Web of Science ®Google Scholar
• Rutter M, Le Couter A, Lord C. (2003). ADI-R, Autism Diagnostic Interview—Revised. Los Angeles, CA: Western Psychological Services [Italian version by Faggioli R, Saccani M, Persico AM, Tancredi R, Parrini B, Igliozzi R, Eds. (2005). Florence, Italy: Organizzazioni Speciali].
   Google Scholar
• Sacco R, Curatolo P, Manzi B, Militerni R, Bravaccio C, Frolli A, Lenti C, Saccani M, Elia M, Reichelt KL, Pascucci T, Puglisi-Allegra S, Persico AM. (2010). Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res 3:237–252.
   PubMed Web of Science ®Google Scholar
• Schopler E, Reichler RJ, Rochen Renner BR. (1986). The Childhood Autism Rating Scale for diagnostic screening and classification of autism. New York, NY: Irvington.
   Google Scholar
• Selmer T, Andrei PI. (2001). p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol. Eur J Biochem 268:1363–1372.
   PubMedGoogle Scholar
• Shaw W. (2010). Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of Clostridia spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia. Nutr Neurosci 13:135–143.
   PubMed Web of Science ®Google Scholar
• Song Y, Liu C, Finegold SM. (2004). Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol 70:6459–6465.
   PubMed Web of Science ®Google Scholar
• Sparrow SS, Balla DA, Cicchetti DV. (1984). Vineland Adaptive Behavior Scales—Survey Form. Circle Pines, MN: American Guidance Service Inc.
   Google Scholar
• Vanholder R, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E, Ringoir S. (1995). Mechanisms of uremic inhibition of phagocyte reactive species production: characterization of the role of p-cresol. Kidney Int 47:510–517.
   PubMed Web of Science ®Google Scholar
• Veenstra-VanderWeele J, Cook EH Jr. (2004). Molecular genetics of autism spectrum disorder. Mol Psychiatry 9:819–832.
   PubMed Web of Science ®Google Scholar
• White JF. (2003). Intestinal pathophysiology in autism. Exp Biol Med (Maywood) 228:639–649.
   PubMed Web of Science ®Google Scholar
• Whiteley P, Waring R, Williams L, Klovrza L, Nolan F, Smith S, Farrow M, Dodou K, Lough WJ, Shattock P. (2006). Spot urinary creatinine excretion in pervasive developmental disorders. Pediatr Int 48:292–297.
   PubMed Web of Science ®Google Scholar
• Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK. (2010). Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 9:2996–3004.
   PubMed Web of Science ®Google Scholar
• Zielinska-Danch W, Wardas W, Sobczak A, Szoltysek-Boldys I. (2007). Estimation of urinary cotinine cut-off points distinguishing non-smokers, passive and active smokers. Biomarkers 12:484–496.
   PubMed Web of Science ®Google Scholar